EU to assess efficacy of COVID-19 vaccine prepared by AstraZeneca

EU to assess efficacy of COVID-19 vaccine prepared by AstraZeneca
  • Clock-gray 12:52
  • calendar-gray 12 January 2021

AstraZeneca has applied to EU Medicines Agency (EMA) to have its vaccine authorised in the EU, President of the EU Commission Ursula von der Leyen wrote on Twitter, APA reports.

"EMA will assess the vaccine’s safety and efficacy. Once the vaccine receives a positive scientific opinion, we will work full speed to authorise its use in Europe," noted Ursula von der Leyen.

Zumrud Pashkin

Other news